Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.38B |
| 2 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$685M |
| 3 |
Home Depot
HD
|
+$497M |
| 4 |
Bausch Health
BHC
|
+$314M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$418M |
| 2 |
AT&T
T
|
+$243M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$193M |
| 4 |
Southern Company
SO
|
+$163M |
| 5 |
DELL
DELL INC
DELL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.21% |
| 2 | Financials | 5.16% |
| 3 | Technology | 4.66% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Energy | 3.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WSR
5251
DELISTED
Whitestone REIT
WSR
| $136K | ﹤0.01% |
10,454
+10,285
| +6,086% | +$139K |
|
|
IPHI
5252
DELISTED
INPHI CORPORATION
IPHI
| $136K | ﹤0.01% |
11,460
+8,760
| +324% | +$112K |
|
|
MVC
5253
DELISTED
MVC Capital, Inc.
MVC
| $136K | ﹤0.01% |
10,326
+2,614
| +34% | +$36.2K |
|
|
UTEK
5254
PUT
DELISTED
Ultratech Inc.
UTEK
| $136K | ﹤0.01% |
4,700
-8,100
| -63% | -$215K |
|
|
LTM
5255
PUT
DELISTED
LIFE TIME FITNESS INC
LTM
| $136K | ﹤0.01% |
2,900
-1,100
| -28% | -$52.6K |
|
5256
Pacific Biosciences
PACB
$373M
| $135K | ﹤0.01% |
26,945
+25,300
| +1,538% | +$116K |
|
5257
CALL
Marriott Vacations Worldwide
VAC
$4.06B
| $135K | ﹤0.01% |
2,600
+1,380
| +113% | +$69.3K |
|
|
MN
5258
DELISTED
MANNING & NAPIER, INC.
MN
| $135K | ﹤0.01% |
7,882
+608
| +8% | +$10.5K |
|
|
LDL
5259
DELISTED
Lydall, Inc.
LDL
| $135K | ﹤0.01% |
7,887
-4,978
| -39% | -$85.9K |
|
|
RP
5260
DELISTED
RealPage, Inc.
RP
| $135K | ﹤0.01% |
5,878
-1,052
| -15% | -$25K |
|
|
LBY
5261
DELISTED
Libbey, Inc.
LBY
| $135K | ﹤0.01% |
6,396
-231
| -3% | -$5.09K |
|
|
RBS.PRT
5262
DELISTED
ROYAL BANK OF SCOTLAND GRP PLS (THE) SPONS ADR REPSTG PFD
RBS.PRT
| $135K | ﹤0.01% |
5,618
| – | – |
|
|
TQNT
5263
PUT
DELISTED
TRIQUINT SEMICONDUCTOR INC
TQNT
| $135K | ﹤0.01% |
16,900
-10,700
| -39% | -$85.4K |
|
|
DNDN
5264
DELISTED
DENDREON CORPORATION
DNDN
| $135K | ﹤0.01% |
67,214
+15,160
| +29% | +$42.6K |
|
5265
Addus HomeCare
ADUS
$2.19B
| $134K | ﹤0.01% |
6,116
+6,044
| +8,394% | +$162K |
|
5266
Astronics
ATRO
$3.85B
| $134K | ﹤0.01% |
5,762
-4,012
| -41% | -$88K |
|
5267
Mitek Systems
MITK
$768M
| $134K | ﹤0.01% |
26,951
+20,657
| +328% | +$120K |
|
5268
CALL
Core Laboratories
CLB
$522M
| $133K | ﹤0.01% |
700
-900
| -56% | -$167K |
|
5269
CALL
Dine Brands
DIN
$452M
| $133K | ﹤0.01% |
1,600
-4,300
| -73% | -$339K |
|
5270
Graham Holdings Company
GHC
$5.13B
| $133K | ﹤0.01% |
331
-11,674
| -97% | -$4.52M |
|
5271
Gildan
GIL
$10.8B
| $133K | ﹤0.01% |
4,982
+278
| +6% | +$6.8K |
|
5272
CALL
RPC Inc
RES
$1.31B
| $133K | ﹤0.01% |
7,800
-1,200
| -13% | -$21K |
|
|
VNET
5273
PUT
VNET Group
VNET
$2B
| $133K | ﹤0.01% |
5,800
-6,700
| -54% | -$128K |
|
|
PRKR
5274
DELISTED
Parkervision Inc
PRKR
| $133K | ﹤0.01% |
3,352
+1,400
| +72% | +$54.1K |
|
|
HNR
5275
PUT
DELISTED
Harvest Natural Resources
HNR
| $133K | ﹤0.01% |
8,300
-1,075
| -11% | -$19.2K |
|
Similar funds
Barclays's Q4 2013 Portfolio in Review
As of Q4 2013, Barclays held 8,027 positions worth $97.6B, up 16% from $83.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $6.87B of net new capital in Q4 2013, opening 582 new positions and adding to 3,285 existing holdings. Its largest new stake was LyondellBasell Industries: 1,615,904 shares worth $129M.
By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 4.2% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $418M trimmed.
- Barclays's largest Q4 2013 buy was LyondellBasell Industries: 1,615,904 shares worth $129M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $3.38B increase.
- Barclays's biggest Q4 2013 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $418M.
- Barclays fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $193M.
- Barclays's ten largest holdings make up 25% of its $97.6B portfolio in Q4 2013.
- Barclays opened 582 new positions and closed 442 in Q4 2013.
- Barclays's portfolio value rose 16% quarter-over-quarter to $97.6B.
Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.